Familial Amyloid Polyneuropathy
Showing 1 - 25 of 1,927
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Not yet recruiting
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- +2 more
-
Auckland, New Zealand
- +2 more
Jan 24, 2023
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy,
Recruiting
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- +2 more
- NTLA-2001
-
Paris, France
- +3 more
Nov 29, 2022
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy Trial (Acoramidis)
Withdrawn
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- (no location specified)
Jan 26, 2022
Familial Amyloidotic Polyneuropathy (BioTRAP)
Completed
- Transthyretin Amyloidosis
- +2 more
-
Rostock, Germany
- +1 more
May 4, 2021
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy Trial in San Francisco (AG10, Placebo)
Withdrawn
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- AG10
- Placebo
-
San Francisco, CaliforniaEidos Therapeutics
Jun 11, 2021
Hereditary Transthyretin Amyloidosis Patients Included in
Completed
- Hereditary Transthyretin Amyloidosis (ATTRv)
- Polyneuropathy
-
Barcelona, Spain
- +2 more
Dec 23, 2022
FAP, Familial Amyloid Polyneuropathy, TTR Trial in Worldwide (IONIS-TTR Rx)
Completed
- FAP
- +4 more
- IONIS-TTR Rx
-
Orange, California
- +21 more
Feb 10, 2021
Hereditary Transthyretin Amyloidosis With Polyneuropthy Trial in Canada, United States (Blood samples for immunoglobulins, Blood
Recruiting
- Hereditary Transthyretin Amyloidosis With Polyneuropthy
- Blood samples for immunoglobulins
- +2 more
-
Rosedale, New York
- +3 more
Dec 19, 2022
Study of Patients With hATTR-PN
Recruiting
- Hereditary Transthyretin Amyloidosis With Polyneuropthy
- Data Collection
-
Anchorage, Alaska
- +22 more
Feb 1, 2023
Amyloid Neuropathies, Transthyretin Amyloidosis Trial in Marseille (Electrophysiological biomarkers, MRI biomarkers)
Completed
- Amyloid Neuropathies
- Transthyretin Amyloidosis
- Electrophysiological biomarkers
- MRI biomarkers
-
Marseille, Paca, FranceAssistance Publique Des Hopitaux de Marseille
Oct 2, 2022
Hereditary Transthyretin Amyloidosis Trial in Roma (Assessment of disease biomarkers)
Recruiting
- Hereditary Transthyretin Amyloidosis
- Assessment of disease biomarkers
-
Roma, ID, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Jun 26, 2023
Transthyretin Amyloid Polyneuropathy (ATTR-PN) Trial in China (tafamidis meglumine)
Active, not recruiting
- Transthyretin Amyloid Polyneuropathy (ATTR-PN)
- tafamidis meglumine
-
Beijing, Beijing, China
- +7 more
Nov 21, 2022
Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Trial in Indianapolis, Boston (Eplontersen)
Recruiting
- Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
-
Indianapolis, Indiana
- +19 more
Jan 31, 2023
High Frequency Imaging in Cerebral Amyloid Angiopathy
Recruiting
- Cerebral Amyloid Angiopathy
- MR Imaging
-
Bonn, Germany
- +2 more
Nov 7, 2023
Cerebral Amyloid Angiopathy Trial in Leiden (Minocycline, Placebo)
Recruiting
- Cerebral Amyloid Angiopathy
- Minocycline
- Placebo
-
Leiden, NetherlandsLeiden University Medical Center
Dec 26, 2022
Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy
Completed
- Cerebral Amyloid Angiopathy
- Siderosis
- None, pure observational study
-
Nîmes, FranceCHU de Nîmes
Dec 5, 2022
At-risk Population for hATTR and Monitoring of TTR Positive
Recruiting
- Transthyretin Amyloidosis
- +4 more
-
Linz, Austria
- +75 more
May 16, 2022
Cerebral Amyloid Angiopathy Trial in Newport Beach, Pasadena (AMDX-2011P)
Not yet recruiting
- Cerebral Amyloid Angiopathy
-
Newport Beach, California
- +1 more
Jan 24, 2023
Mixed Phenotype Hereditary Transthyretin Amyloidosis
Not yet recruiting
- Hereditary Transthyretin Amyloidosis (ATTRv) Cardiomyopathy (CM), Mixed Phenotype
- (no location specified)
Dec 8, 2022
Periventricular White Matter Hyperintensities in Cerebral
Not yet recruiting
- Cerebral Amyloid Angiopathy
- Hypertensive Arteriopathy
- None, pure observational study
- (no location specified)
Aug 2, 2022
Patients With hATTR With Polyneuropathy Treated With Patisiran
Not yet recruiting
- Transthyretin Amyloidosis
- Amyloidosis, Hereditary
- Six minutes walk test
-
Bordeaux, France
- +7 more
May 24, 2023
RWE-based Treatment Patterns and Outcomes in CIDP
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy
- +2 more
- No intervention. Retrospective observation only.
-
Salford, United KingdomNorthern Care Alliance NHS Foundation Trust
Jul 7, 2023
Cerebral MRI Anomalies in Mutated Transthyretin Amyloidosis
Completed
- Transthyretin Amyloidosis
- No intervention,
-
Nîmes, FranceCHU de Nîmes
Sep 1, 2022
Transthyretin Amyloidosis Trial in Beijin (Tafamidis Pill)
Recruiting
- Transthyretin Amyloidosis
- Tafamidis Pill
-
Beijin, ChinaPeking University Third Hospital
Jul 7, 2021
Cerebral Amyloid Angiopathy, Small Vessel Cerebrovascular Disease, Cadasil Trial in Bern
Recruiting
- Cerebral Amyloid Angiopathy
- +3 more
-
Bern, SwitzerlandDepartment of Neurology, Inselspital Bern University Hospital
Feb 8, 2023